Replies to post #470280 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

I do agree that the NWBO stock price is likely to increase after the DCVax-L primary and secondary endpoints are updated on clinicaltrial.org.

But, I don't believe that the company is interested in doing anything that will only produce a short-term increase in share price. As the company has stated previously, they are more interested in getting regulatory approvals for DCVax-L in the US, UK, Canada, Germany and the rest of the EU. Then, the stock price will take care of itself, on a long-term basis.